Endoscopy finds cancer in a small percentage of procedures. In screening colonoscopies, about 1.1% of patients receive a colorectal cancer diagnosis at the time of their procedure. For upper endoscopies, the detection rate is similarly low for most patients, though it rises with age and the presence of warning symptoms. If you’re heading into an endoscopy and wondering about the odds, the vast majority of procedures find either nothing concerning or benign conditions that can be monitored or treated.
Cancer Detection Rates by Procedure Type
The numbers vary depending on whether you’re having a colonoscopy (lower GI) or an upper endoscopy (examining the esophagus and stomach), and whether the procedure is for routine screening or because you have symptoms.
In a large study of screening colonoscopies, 1.4% of men and 0.8% of women were diagnosed with colorectal cancer at their baseline procedure. Combined, that’s roughly 1 in 90 people. These were asymptomatic patients getting screened, not people with bleeding or other red flags. The detection rate for diagnostic colonoscopies, performed because something prompted a closer look, tends to be higher.
Upper endoscopies follow a similar pattern. Most are performed for reflux, ulcers, or persistent stomach discomfort, and the majority reveal non-cancerous explanations. Cancers of the esophagus and stomach are typically asymptomatic in early stages, which means they’re more often found when they do cause symptoms, and by that point the disease may be more advanced.
How Age Affects the Odds
Your age is one of the strongest predictors of whether an endoscopy will find cancer. In a large analysis of colonoscopy results, the carcinoma detection rate for patients aged 45 to 54 was about 0.29%. That rate began climbing at age 55, reaching 0.33% in the 55 to 59 group, 0.41% in the 60 to 64 group, and holding near 0.41% in the 70 to 74 group. These differences are statistically significant compared to younger patients.
Put another way, a 65-year-old getting a colonoscopy is roughly 40% more likely to have cancer detected than a 48-year-old, though the absolute risk remains below 1 in 200 for both groups. This age-related increase is one reason screening guidelines recommend starting at 45.
When Symptoms Raise the Risk
If you’re having an endoscopy because of specific warning signs, the likelihood of finding something serious goes up. For upper GI cancers, the most common symptoms that eventually lead to a diagnosis include unexplained weight loss (present as a first symptom in about 60% of gastric and esophageal cancer patients), difficulty swallowing (43%), and iron deficiency anemia. The catch is that these symptoms usually appear once the cancer is already advanced, not in its earliest and most treatable stages.
For colonoscopies, symptoms like rectal bleeding, a change in bowel habits, or unexplained anemia shift the procedure from “screening” to “diagnostic,” and the cancer detection rate rises accordingly. The specific increase depends on the combination of symptoms, but having one or more alarm signs makes a cancer finding meaningfully more likely than it would be during a routine screen.
Barrett’s Esophagus and Progression Risk
If you’ve been told you have Barrett’s esophagus, a condition where the lining of the lower esophagus changes due to chronic acid exposure, you may be wondering about your cancer risk at surveillance endoscopies. The progression rate depends on where you fall on the spectrum.
For patients with non-dysplastic Barrett’s (no abnormal cell changes), the rate of developing esophageal adenocarcinoma is about 0.21% per year. That means roughly 1 in 500 patients per year of monitoring. If low-grade dysplasia is present, the rate climbs to about 1.16% per year. With high-grade dysplasia, the most concerning pre-cancerous stage, the annual progression rate jumps to about 14%, which is why treatment is typically recommended at that point rather than continued surveillance alone.
What Endoscopy Can Miss
No test is perfect, and endoscopy occasionally misses cancers that are already present. A population-based study from Norway found that 9.2% of gastric cancers had been missed during an endoscopy performed 6 to 36 months before the eventual diagnosis. A broader meta-analysis of 22 studies found a nearly identical miss rate of 9.4%. In Western countries, reported miss rates for stomach cancer range from about 5% to 10%.
Several factors contribute to missed cancers. Some early tumors look subtle, resembling mild inflammation or a small ulcer. Others may be located in hard-to-visualize areas of the stomach. The skill and thoroughness of the doctor performing the procedure also matters. For colonoscopies, physicians who detect precancerous polyps (adenomas) at higher rates have patients with lower cancer risk afterward. Specifically, doctors whose adenoma detection rate falls below 26% have patients with measurably higher rates of cancer appearing after the procedure, compared to doctors who meet or exceed that threshold.
What Happens If Something Looks Suspicious
During the endoscopy itself, your doctor will take tissue samples (biopsies) from anything that looks abnormal. Results typically come back within a few days to two weeks. Most biopsies come back benign or show inflammation, not cancer.
If a biopsy shows possible pre-cancerous changes, the next step is often a short course of treatment followed by a repeat endoscopy with new biopsies in 4 to 6 weeks. This is because inflammation can sometimes mimic early pre-cancerous changes under the microscope, and treating the inflammation first helps pathologists get a clearer picture.
If cancer is confirmed, the timeline moves more quickly. Imaging scans are typically ordered to determine whether the cancer has spread and to guide treatment planning. For very early cancers confined to the surface lining, removal during endoscopy itself may be possible, with annual follow-up endoscopies afterward. For more advanced stages, a structured follow-up schedule begins after treatment, with check-ins and repeat procedures at regular intervals over the following five years.
Putting the Numbers in Perspective
For the average person going in for a screening endoscopy, cancer is found in roughly 1 out of every 100 procedures or fewer. Your individual risk depends on your age, symptoms, family history, and what condition prompted the procedure in the first place. The purpose of endoscopy isn’t just to find cancer. It’s also to find and remove precancerous polyps or monitor conditions like Barrett’s esophagus before they ever become cancer. In colonoscopy specifically, this preventive function is arguably more important than the cancer detection itself, since removing polyps during the procedure can prevent cancer from developing in the first place.